ckosmidis Profile Banner
Chris Kosmidis Profile
Chris Kosmidis

@ckosmidis

Followers
955
Following
1K
Media
20
Statuses
636

Infectious Diseases Physician and Researcher, University of Manchester. Interested in all aspergillosis clinical syndromes, invasive, allergic and chronic.

Manchester, UK
Joined May 2009
Don't wanna be here? Send us removal request.
@ckosmidis
Chris Kosmidis
4 months
Dear friends:.If you diagnose patients with chronic pulmonary aspergillosis, you can help us! Short survey on how you use Aspergillus IgG in #CPA. Your answers will help understand how CPA is diagnosed globally! @eurconfmedmycol @CPAnetResearch @MFT_NAC .
Tweet card summary image
forms.office.com
0
6
5
@ckosmidis
Chris Kosmidis
7 days
RT @ProfJDChalmers: New in @ERSpublications @MereteLong from @dundeeuni discussing interesting new data on IL-33 in COPD from FRONTIER-4.IL….
0
20
0
@ckosmidis
Chris Kosmidis
7 days
RT @MFT_NAC: Listening to other people's experiences helps patients come to terms with their diagnosis and feel less alone. @TGBermingham h….
0
2
0
@ckosmidis
Chris Kosmidis
17 days
Increasing interest in the role of Aspergillus in bronchiectasis outcomes. Aspergillus serology should become part of routine care, and management should be individualised. @MFT_NAC @BTSrespiratory @ProfJDChalmers.
@accpchest
CHEST
21 days
New findings highlight a need to integrate #Aspergillus serologies into routine #bronchiectasis care and adopt a phenotype-driven, personalized approach to fungal surveillance and treatment. 🔗 Read more in CHEST Physician:
Tweet media one
0
10
19
@ckosmidis
Chris Kosmidis
17 days
RT @MFT_NAC: 📢 Calling all respiratory & infectious disease clinicians:.Have a patient with chronic pulmonary aspergillosis (CPA) starting….
0
3
0
@ckosmidis
Chris Kosmidis
21 days
RT @FungalDoc: We are recruiting Transplant ID physicians into a vibrant and diverse group with active research and patient care. Looking….
0
10
0
@ckosmidis
Chris Kosmidis
22 days
🔬 Delighted to offer a PhD @OfficialUoM: personalise antifungal therapy for chronic lung disease. Work on big-data + precision-medicine trial to boost outcomes in asthma/COPD/bronchiectasis. Clinicians & scientists welcome. Apply year-round 👉 @MFT_NAC.
Tweet card summary image
findaphd.com
PhD Project - Personalised approach to antifungal treatment in chronic fungal lung disease at The University of Manchester, listed on FindAPhD.com
0
3
11
@ckosmidis
Chris Kosmidis
28 days
The exact immune dysfunction in patients with chronic pulmonary aspergillosis is not known. In our recent paper we show that this dysfunction is centered around dendritic cells, leading to reduced IL12 production. ⁦@MFT_NAC⁩ ⁦@NACincas
Tweet card summary image
pubmed.ncbi.nlm.nih.gov
Our findings suggest that immune dysfunction in CPA involves DC and monocyte impairments, potentially contributing to IFNγ deficiency through reduced IL-12 production and co-stimulatory capacity in...
0
4
11
@ckosmidis
Chris Kosmidis
1 month
RT @Fungaldx: Dear Colleagues,.We are pleased to announce FungalDx26, which will take place on December 2–3, 2026, in Bethesda, MD, USA. D….
Tweet card summary image
fungaldx.com
Fungal Dx 26 📅 Dec 2–3, 2026 📍 Bethesda, MD, USA 🌐 www.fungaldx.com
0
5
0
@ckosmidis
Chris Kosmidis
1 month
RT @MFT_NAC: If you’re at #BTSSummer2025 come to the @MFT_NAC stall to see how we can help YOU support chronic aspergillosis patients (even….
0
3
0
@ckosmidis
Chris Kosmidis
1 month
RT @MFT_NAC: Who's going to #BTSSummer2025 tomorrow?. Come and say hi 👋 to the National Aspergillosis Centre team at stand G (turn left jus….
0
1
0
@ckosmidis
Chris Kosmidis
1 month
RT @MFT_NAC: 📢 Calling all respiratory & infectious disease clinicians:.Have a patient with chronic pulmonary aspergillosis (CPA) starting….
0
3
0
@ckosmidis
Chris Kosmidis
2 months
RT @MFT_NAC: 📢 Calling all respiratory & infectious disease clinicians:.Have a patient with chronic pulmonary aspergillosis (CPA) starting….
0
2
0
@ckosmidis
Chris Kosmidis
2 months
Heading to @ISHAM_Mycology meeting! Hope to see many of you there!.Looking forward to contributing to sessions on chronic fungal lung disease on Wednesday and serological diagnosis of CPA on Friday. @MFT_NAC.
0
2
11
@ckosmidis
Chris Kosmidis
2 months
RT @NormanRhijn: Brazilian TV had a long section about fungal pathogens, AMR and the future risks of fungi🔥thoroughly enjoyed the filming d….
0
8
0
@ckosmidis
Chris Kosmidis
3 months
RT @forestcita: Don't forget to register and send your abstract for #BSMM2025 @NorwichCC @Assembly_House DEADLINE I….
0
5
0
@ckosmidis
Chris Kosmidis
3 months
RT @MFT_NAC: CPA affects ~3,600 people in the UK. Mortality can reach 40% at 5 years. Current treatment = long-term azoles with limited eff….
0
4
0
@ckosmidis
Chris Kosmidis
3 months
RT @MFT_NAC: 📢 Calling all respiratory & infectious disease clinicians:.Have a patient with chronic pulmonary aspergillosis (CPA) starting….
0
3
0
@ckosmidis
Chris Kosmidis
3 months
Study recruiting now. Respiratory and ID clinicians: if you start patients on azoles for chronic aspergillosis they may be eligible to also receive interferon gamma via our RCT. Our preliminary data shows reduction in flares with IFNg @MFT_NAC.
@MFT_NAC
National Aspergillosis Centre
3 months
💬 “First reaction is to encourage patients to chase the chance of having Gamma Interferon.”.– A CPA patient reflecting on past trial experience. Encourage your patients to take part in the INCAS trial and help build the future of CPA care. 📨 Contact NAC for referral info.#C .
Tweet media one
0
0
2